How to Evaluate a Research Peptide Supplier
By Ouralus · Published · For laboratory research use only.
Most research peptide suppliers look alike from the outside: clean product photography, high purity figures, fast shipping. The differences that matter sit underneath, in the documentation, and they can be checked by anyone willing to spend twenty minutes. This guide is a documentation-first checklist for judging a supplier: what to ask for, how to test the answers, and which answers should end the evaluation.
Start with what can be checked
A supplier's own statements about quality are the least useful evidence you have, because they cannot be tested. "Lab-tested", "high purity" and "premium quality" are claims. A report with a laboratory name, a task number and a verify key is evidence, because you can take it to someone other than the supplier and ask whether it is real. The whole evaluation below is about converting claims into checkable records, and noticing where that conversion fails.
1. Are the reports independent and named?
Look for a named third-party laboratory on each report. The laboratory should not be the supplier, a sister company or an unnamed "partner lab". Ask yourself whether you could contact the laboratory without going through the supplier. If you could not, the report is functioning as marketing, not as evidence.
2. Can every report be verified at the source?
A verifiable report carries a reference the issuing laboratory will confirm: a task number, a verify key, or both. Take one or two at random and check them on the laboratory's own site. Do not stop at the first one that verifies; a supplier with one genuine report and twenty edited copies is a known pattern. The step-by-step method is inhow to verify a research peptide certificate of analysis.
3. Does each report match the listing it sits on?
Read the sample name and size on the report, then the compound and size on the product page. They should agree. Where a compound is sold in more than one vial size, check whether each size has its own report or whether one report is shown against all of them. A report for a 10 mg vial does not describe a 5 mg vial filled separately. Also check that the purity figure on the listing is the figure on the report, to the same decimal places. A listing that rounds 99.18% up to "99.9%" has rewritten the evidence.
4. Can a report be traced to a lot and a date?
Every report has an analysis date. Ask how that date relates to the stock being sold now. A supplier that tracks lots can tell you which lot a report belongs to and whether it is the lot currently shipping. A supplier that cannot answer that question is showing you a certificate for material you may never receive. Be wary of blanket statements that all lots are tested when the site shows one report per compound: the paperwork does not support the claim.
5. Does the supplier say plainly where reports are missing?
No supplier has a current report for every product at every moment. New compounds arrive before their reports, and some materials are reported by content only. What separates suppliers is whether those gaps are visible. A good sign is a product page that says plainly when no certificate has been published, and claims no figure until one is. A bad sign is a generic certificate image reused on products it does not belong to, or wording that implies coverage the paperwork lacks.
6. Do the claims stay inside the paperwork?
Compare what the supplier says about testing with what the reports actually print. If the reports show purity and content, the supplier should not describe its material as identity-confirmed, sterile, endotoxin-tested or heavy-metal-screened. Terms like "pharmaceutical grade" or references to manufacturing standards should come with documents that support them. Overclaiming on testing is a reliable signal: a supplier willing to stretch what a report says will stretch other things too.
7. Is the compound data published and consistent?
A research supplier should publish basic chemical data for each compound: name, sequence where it is a peptide, molecular formula, molecular weight, CAS number where one exists, physical form and the quantity per vial. Check that these agree across the product page, the label and any specification sheet, and that they agree with a public reference such as PubChem. Inconsistent molecular formulas between two pages of one site are a sign that nobody is checking the data.
8. Are storage and shipping documented?
Lyophilised peptides are most stable kept cold, dry and away from light, in the sealed form they ship in. A supplier should state the form a compound ships in, the storage conditions it recommends, and how it packages for transit. Vague or absent storage guidance suggests the supplier is not thinking about what happens to the material after it leaves.
9. Does the supplier stay in a research-supply posture?
A research chemical supplier sells characterised material and documents it. It does not publish amounts, schedules or routes for its compounds, and it does not answer questions about personal use. A supplier that does is selling to a different market under a research label, and its documentation standards tend to follow its marketing.
10. Is there a business you can hold to account?
Look for a business name, a physical address, a working contact email, published terms and a returns or replacement policy. None of these prove quality, but their absence removes your ability to raise a problem with anyone.
A quick scorecard
| Check | Pass | Fail |
|---|---|---|
| Named third-party lab | Lab named on every report | No lab, or supplier-branded only |
| Verifiable | Task number and key confirm at the lab | No key, or key does not confirm |
| Listing match | Compound, size and figures agree with the report | One report on many listings, or rounded figures |
| Lot and date | Supplier can say which lot a report covers | No answer, or "all lots tested" with no reports to show it |
| Gaps disclosed | Products without a report are marked as such | Generic certificate reused across products |
| Claims in scope | Testing claims match what reports print | Identity or sterility claimed without a report |
Worked example: one listing, checked
Here is our MOTS-c 20 mg report, shown the way it appears in our public COA feed. Each report prints the sample name, the measured quantity per vial, a purity figure where the lab reported one, the analysis date and a verify key. It does not print an identity result or name the analytical method.
| Laboratory | Janoshik Analytical |
|---|---|
| Task number | 165287 |
| Batch field, as printed | Red Cap |
| Measured content per vial | 21.93 mg |
| Purity, as printed | 99.181% |
| Analysis date | 2026-05-28 |
| Verify key | 7YZ1RD26WYGQ |
The 20 mg and 10 mg sizes of MOTS-c are separate fills with separate reports, so each size on the product page shows its own task number and figures. The batch field is a cap colour, which you can match against the vial you receive.
Open the report imageBatch pageMOTS-c product pageCheck it at Janoshik
Running the checklist: the laboratory is named (check 1); the task number and key confirm at Janoshik (check 2); the report is for the 20 mg size, and the MOTS-c product page shows it against that size only (check 3); the batch field and date are printed (check 4); our testing page lists every report on file, and a product without one reads "No certificate published yet" on its page (check 5); and our testing claims stop at purity and content (check 6).
Where we stand
Batch tested by Janoshik Analytical. Verify any report with its key on Janoshik's site. We would rather you run this checklist on us than take our word for anything. Start with any report:Semax, DSIP orFOXO4-DRI are all published with their keys. For what each record in a supplier's paperwork should contain, see research peptide documentation and quality standards.
Research use only. This checklist judges documentation, not suitability for any use. Ouralus materials are supplied for laboratory research use only and are not for human or animal use.
